Uncategorized 29 Oct 2025 BioNet Achieves EU-GMP Certification for its Pertussis Vaccine Manufacturing BioNet
Uncategorized 19 Jun 2025 Avidity of pertussis toxin antibodies following vaccination with genetically versus chemically detoxified pertussis toxin-containing vaccines during pregnancy Avidity of pertussis toxin antibodies following vaccination with genetically versus chemically detoxified pertussis toxin-containing vaccines during pregnancy Both the… Pantitra Laohatranon
Uncategorized 18 Apr 2025 How to improve pertussis vaccination in pregnancy: a European expert review How to improve pertussis vaccination in pregnancy: a European expert review Pertussis (whooping cough) remains a serious threat to infants,… BioNet
Uncategorized 11 Apr 2025 New Research Boosts Future Whooping Cough Vaccines Whooping cough, or pertussis, was once a leading cause of death for children in the U.S. and worldwide before the… Pantitra Laohatranon
Uncategorized 25 Feb 2025 Thailand Leads the Way with World’s First Stand-alone Pertussis Vaccine Program for Pregnant Women Thailand Leads the Way with World's First Stand-alone Pertussis Vaccine Program for Pregnant Women Thailand's National Health Security Office (NHSO)… BioNet
Uncategorized 17 Jan 2025 BioNet Wins BARDA Patch Forward Prize for Microneedle mRNA Vaccine Innovation Lyon, France & Bangkok, Thailand – January 17, 2025 – BioNet, a global leader in vaccine innovation, proudly announces its… BioNet
